Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. - Mitra, A.; Fisher, C.; Foster, C. S.; Jameson, C.; Barbachanno, Y.; Bartlett, J.; Bancroft, E.; Doherty, R.; Kote-Jarai, Z.; Peock, S.; Easton, D.; Eeles, R.; et al. (British Journal of Cancer, 2008)